Characterization of the apoptotic response of human leukemia cells to organosulfur compounds

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Wong, W Wei Lynn ^a,b,e   Boutros, Paul C ^a,b,f   Wasylishen, Amanda R ^a,b   Guckert, Kristal D ^d   O'Brien, Erin M ^d   Griffiths, Rebecca ^a   Martirosyan, Anna R ^a   Bros, Christina ^a   Jurisica, Igor ^a,b,c   Langler, Richard F ^d   Penn, Linda Z ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT ALLISON UNIVERSITY   (Canada)

^e LA TROBE UNIVERSITY   (Australia)

^f ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ORGANOSULFUR DERIVATIVE; PROTEIN P53; TRANSCRIPTION FACTOR; ANTINEOPLASTIC AGENT; DISULFIDE; SULFONE;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; DNA FLANKING REGION; DNA MODIFICATION; DRUG MECHANISM; DRUG STRUCTURE; DYSOXYLUM RICHI; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEDICINAL PLANT; PROMOTER REGION; STRUCTURE ACTIVITY RELATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LEUKEMIA; METABOLISM; MYELOID PROGENITOR CELL; PATHOLOGY; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BINDING SITES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DISULFIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA; MOLECULAR STRUCTURE; MYELOID PROGENITOR CELLS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONES;

EID: 77954078542     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-351     Document Type: Article

References (33)

1. Evan G, Littlewood T. A matter of life and cell death. Science 1998, 281(5381):1317-1322. 10.1126/science.281.5381.1317, 9721090.
2. Lundberg AS, Weinberg RA. Control of the cell cycle and apoptosis. Eur J Cancer 1999, 35(4):531-539. 10.1016/S0959-8049(99)00292-0, 10492624.
3. Letai AG. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 2008, 8(2):121-132. 10.1038/nrc2297, 18202696.
4. Sriram N, Kalayarasan S, Ashokkumar P, Sureshkumar A, Sudhandiran G. Diallyl sulfide induces apoptosis in Colo 320 DM human colon cancer cells: involvement of caspase-3, NF-kappaB, and ERK-2. Mol Cell Biochem 2008, 311(1-2):157-65. 10.1007/s11010-008-9706-8, 18256791.
5. Shukla Y, Kalra N. Cancer chemoprevention with garlic and its constituents. Cancer Lett 2007, 247(2):167-181. 10.1016/j.canlet.2006.05.009, 16793203.
6. Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki K, Tsubura A. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 2001, 22(6):891-897. 10.1093/carcin/22.6.891, 11375895.
7. Wong WW, Macdonald S, Langler RF, Penn LZ. Novel synthetic organosulfur compounds induce apoptosis of human leukemic cells. Anticancer Res 2000, 20(3A):1367-1374.
8. Griffiths R, Wong WW, Fletcher SP, Penn LZ, Langler RF. Novel Disulfides with Antitumour Efficacy and Specificity. Australian Journal of Chemistry 2005, 58(2):128-136.
9. Rocke DM, Durbin B. A model for measurement error for gene expression arrays. J Comput Biol 2001, 8(6):557-569. 10.1089/106652701753307485, 11747612.
10. Smyth GK. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Stat App Genet Mol Biol 2003, 3(1):1-26.
11. Efron B, Tibshirani R. Empirical bayes methods and false discovery rates for microarrays. Genet Epidemiol 2002, 23(1):70-86. 10.1002/gepi.1124, 12112249.
12. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990, 215(3):403-410.
13. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan S, Kane DW, Reinhold WC, Lababidi S, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003, 4(4):R28. 10.1186/gb-2003-4-4-r28, 154579, 12702209.
14. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, et al. The UCSC Genome Browser Database. Nucleic Acids Res 2003, 31(1):51-54. 10.1093/nar/gkg129, 165576, 12519945.
15. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 2004, (32 Database):D91-94. 10.1093/nar/gkh012, 308747, 14681366.
16. Frith MC, Fu Y, Yu L, Chen JF, Hansen U, Weng Z. Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res 2004, 32(4):1372-1381. 10.1093/nar/gkh299, 390287, 14988425.
17. Langler RF. a-Thiodisulfides: construction and biological activities. Journal of Sulfur Chemistry 2008, 29(1):99-127.
18. Blight BA, Langler RF, Thompson DB, Ross CR. Synthesis and X-ray crystal structures of selected ω-mercaptosulfones. Journal of Sulfur Chemistry 2006, 27(6):571-582.
19. Kasugai S, Hasegawa N, Ogura H. A simple in vito cytotoxicity test using the MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) colorimetric assay: analysis of eugenol toxicity on dental pulp cells (RPC-C2A). Jpn J Pharmacol 1990, 52(1):95-100. 10.1254/jjp.52.95, 2308240.
20. Wong WW, Clendening JW, Martirosyan A, Boutros PC, Bros C, Khosravi F, Jurisica I, Stewart AK, Bergsagel PL, Penn LZ. Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. Mol Cancer Ther 2007, 6(6):1886-1897. 10.1158/1535-7163.MCT-06-0745, 17575117.
21. Choy H. Taxanes in combined modality therapy for solid tumors. Crit Rev Oncol Hematol 2001, 37(3):237-247. 10.1016/S1040-8428(00)00112-8, 11248579.
22. Boutros PC, Okey AB. Unsupervised pattern recognition: an introduction to the whys and wherefores of clustering microarray data. Brief Bioinform 2005, 6(4):331-343. 10.1093/bib/6.4.331, 16420732.
23. Pan KH, Lih CJ, Cohen SN. Effects of threshold choice on biological conclusions reached during analysis of gene expression by DNA microarrays. Proc Natl Acad Sci USA 2005, 102(25):8961-8965. 10.1073/pnas.0502674102, 1149502, 15951424.
24. Wasserman WW, Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 2004, 5(4):276-287. 10.1038/nrg1315, 15131651.
25. Das A, Banik NL, Ray SK. Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer 2007, 110(5):1083-1095. 10.1002/cncr.22888, 17647244.
26. Jo HJ, Song JD, Kim KM, Cho YH, Kim KH, Park YC. Diallyl disulfide induces reversible G2/M phase arrest on a p53-independent mechanism in human colon cancer HCT-116 cells. Oncol Rep 2008, 19(1):275-280.
27. Baerlocher FJ, Langler RF, Frederiksen MU, Georges NM, Witherell RD. Structure-Activity Relationships for Selected Sulfur-Rich Antifungal Compounds. Australian Journal of Chemistry 1999, 52(3):167-172.
28. Baerlocher FJ, Baerlocher MO, Guckert KD, Langler RF, MacQuarrie SL, O'Connor PE, Sung GCY. Selected a, a'-Dimethyl Disulfides: Submicrogram Fungitoxins. Australian Journal of Chemistry 2001, 54(6):397-400.
29. Kong G, Kain KC, Crandall I, Langler RF. Novel disulfides as anticancer/antimalarial agents. Sulfur Letters 2003, 26(4):149-154.
30. MacDonald JA, Marchand ME, Langler RF. Improving upon the in vitro biological activity of antithrombotic disulfides. Blood Coagul Fibrinolysis 2004, 15(6):447-450. 10.1097/00001721-200408000-00002, 15311152.
31. MacDonald JA, Langler RF. Structure-activity relationships for selected sulfur-rich antithrombotic compounds. Biochem Biophys Res Commun 2000, 273(2):421-424. 10.1006/bbrc.2000.2950, 10873621.
32. Rampersad GC, Suck G, Sakac D, Fahim S, Foo A, Denomme GA, Langler RF, Branch DR. Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells. Transfusion 2005, 45(3):384-393. 10.1111/j.1537-2995.2005.04241.x, 15752156.
33. Foo AH, Fletcher SP, Langler RF, Porter CH, Branch DR. Structure-function studies for in vitro chemical inhibition of Fc gamma receptor-mediated phagocytosis. Transfusion 2007, 47(2):290-298. 10.1111/j.1537-2995.2007.01105.x, 17302776.